CSL Limited (ASX: CSL) - Financials

Current share price for CSL : $180.720 2.42 (1.36%)⁺

CSL (CSL Limited) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology.

CSL Per Share

Year to Jun	Sales	Cashflow	Earnings	Dividends	Franking	Book Value	Average Annual P/E	Relative P/E	Shareholder Return
2026	$47.40	1060.8 ¢	1614.2 ¢	425.1 ¢	0%	$45.00	10.87	67.6%	-50.9%
2025	$48.40	1117.4 ¢	932.6 ¢	445.8 ¢	0%	$61.00	29.48	211.3%	-17.6%
2024	$45.70	860.8 ¢	839.6 ¢	398.6 ¢	0%	$54.20	32.46	234.9%	8%

CSL Capital Structure

Total Debt	Interest	Long Term Debt	Percent Debt	Preferred Stock	Share Equity	Percent Equity
$15,862,571	$633,280	$14,200,029	40%	$0.00	$21,541,709	60%

Note: All dollars in thousands ('000) for the table above

CSL Historical Financials

	2026	2025	2024
Revenue ($M)	22,853.4	23,557.3	22,176.9
Operating Margin (%)	33.7	33.2	32.7
Depreciation ($M)	-808	-838.2	-797.1
Amortisation ($M)	-708	-715	-619
Net Profit Before Abs ($M)	7,779.9	4,537.4	4,070
Net Profit After Abs ($M)	-3,754.5	4,583.2	3,988.5
Income Tax Rate (%)	26.9	15.8	19.6
Net Profit Margin (%)	34	19.3	18.4
Employees ($T)	29	29.9	32
Long Term Debt ($M)	14,200	16,326.7	16,967.1
Shareholders Equity ($M)	21,541.7	29,519.1	26,212.3
Return on Capital (%)	23	11	11
Return on Equity (%)	36.1	15.4	15.5
Payout Ratio (%)	26	48	47

CSL Cashflow

	2026	2025	2024
Customer Receipts ($M)
Net Operating Cashflow ($M)	5,113	5,437	4,173
Net Investing Cashflow ($M)	-1,850	-1,298	-1,901
Net Financing Cashflow ($M)	-4,117	-3,421	-1,938

CSL Market & Earnings

	2026	2025	2024
Market Cap ($M)	54,950	115,959	142,661
Net Gearing (%)	57.5	43.6	54.2
Net Interest Cover (%)	10.47	10.01	8.85
Dividend Yield (%)	3.5	1.9	1.4
NTA Per Share ($)	11.65	9.93	3.18
EBITDA ($M)	7,690	7,818	7,252
EBIT ($M)	6,174	6,266	5,836
EBT Before Abs ($M)	5,585	5,640	5,177

CSL Balance Sheet

	2026	2025	2024
Cash ($M)	2,203	3,293	2,502
Debtors ($M)	3,951	3,453	3,125
Other Debtors ($M)	719.2	946.6	862
Prepayments ($M)	493.5	395.4	383.5
Inventories ($M)	9,648	9,872	9,004
Current Investments ($M)
Other Current Assets ($M)	211.1	131.3	190.2
Total Current Assets ($M)	17,225	18,092	16,256
Receivables ($M)	361	288.5	238.5
Inventories ($M)
Property, Plant & Equipment ($M)	21,073	21,586	20,448
Accumulated Depreciation ($M)	-9,116	-6,629	-5,868
Intangibles ex. Goodwill ($M)	6,695	12,397	12,480
Goodwill ($M)	9,266	12,313	12,197
Future Income Tax Benefit ($M)	3,241	1,666	1,375
Non-Current Investments ($M)	224.2	309.9	246.1
Other Non-Current Assets ($M)	13.1	135.9	27.2
Total Non-Current Assets ($M)	31,757	42,067	41,144
Total Assets ($M)	48,982	60,159	57,400
Accounts Payable ($M)	5,059	5,284	5,050
Provisions ($M)	1,072.9	839.7	982.8
Short Term Debt ($M)	1,663	1,227	1,425
Other Current Liabilities ($M)
Total Current Liabilities ($M)	7,794	7,351	7,473
Creditors ($M)	375.6	439.7	347.2
Long Term Debt ($M)	14,200	16,327	16,967
Provisions ($M)	2,516	3,012	2,992
Other Non-Current Liabilities ($M)	356.7	346.6	332.1
Total Non-Current Liabilities ($M)	17,448	20,125	20,639
Total Liabilities ($M)	25,242	27,476	28,111
Share Capital ($M)	-174.7	876.3	840.9
Reserves ex. Share Premium ($M)	1,775	1,553	1,199
Share Premium Reserve ($M)
Retained Profits ($M)	19,942	27,090	24,173
Other Shareholders Equity ($M)
Convertible Equity ($M)
Outside Equity Interest ($M)	2,198	3,163	3,077
Total Shareholders Equity ($M)	23,740	32,682	29,289

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us